Our Company
Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results
Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results

New Brunswick, NJ (June 30, 2020) - Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:00 a.m. (Eastern Time) on Thursday, July 16th to review second-quarter results. Joseph J. Wolk, Executive Vice President, Chief Financial Officer and Christopher DelOrefice, Vice President, Investor Relations will host the call. The question and answer portion of the call will also include additional members of Johnson & Johnson’s executive team.

Investors and other interested parties can access the webcast/conference call in the following ways:

  • The webcast and presentation material are accessible at Johnson & Johnson’s website www.investor.jnj.com. A replay of the webcast will be available approximately three hours after the conference call concludes.
  • By telephone: for both “listen-only” participants and those financial analysts who wish to take part in the question-and-answer portion of the call, the telephone dial-in number in the U.S. is 877-869-3847. For participants outside the U.S., the dial-in number is 201-689-8261.
  • A replay of the conference call will be available until approximately 12:00 a.m. on July 30th, 2020. The replay dial-in number for U.S. participants is 877-660-6853. For participants outside the U.S., the replay dial-in number is 201-612-7415. The replay conference ID number for all callers is 13705337.
  • The press release will be available at approximately 6:45 a.m. (Eastern Time) the morning of the conference call.
  • Please refer to www.investor.jnj.com for a complete list of currently planned 2020 earnings webcast/conference calls. Please note the third-quarter date of Tuesday, October 13th, 2020.

About Johnson & Johnson At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That’s why for more than 130 years, we have aimed to keep people well at every age and every stage of life. Today, as the world’s largest and most broadly-based health care company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere. We are blending our heart, science and ingenuity to profoundly change the trajectory of health for humanity.

  • Press Contacts:
    Cristal Downing
    (732) 524-3283
    (908) 616-8833 (M)

    Investor Contacts:
    Christopher DelOrefice
    (732) 524-2955

    Matthew Stuckley
    (732) 524-2617
This site uses cookies as described in our Cookie Policy. Please click the "Accept" button or continue to use our site if you agree to our use of cookies.
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Continue